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ABSTRACT
Objective: Naringenin is a dietary biomolecule with broad spectrum of activities which protects neurons from various neurotoxic insults and improves 
cognition and motor function in neurodegenerative diseases. DJ-1 has both, ubiquitin E3 ligase as well as chaperonic activity, and loss of ubiquitin E3 
ligase activity of DJ-1 has been found to be associated with familial Parkinson’s disease (PD). Naringenin induced E3 ligase activity of DJ-1 which can 
have possible clinical relevance in PD.
Methods: Various in silico parameters such as phylogenetic analysis, homology modeling, active site prediction, and molecular docking studies using 
AutoDock 4.2.1 and LIGPLOT1.4.5 were carried out.
Results: Three-dimensional structure of DJ-1 was generated and Ramachandran plot was obtained for quality assessment. RAMPAGE displayed 
99.5% of residues in the most favored regions. 0% residues in additionally allowed and 0.5% disallowed regions of DJ-1 protein. Further, initial 
screenings of the molecules were done based on Lipinski’s rule of five. CastP server used to predict the ligand binding site suggests that this protein 
can be utilized as a potential drug target. Finally, we have found naringenin to be most effective among four biomolecules in modulating DJ-1 based 
on minimum inhibition constant, Ki, and highest negative free energy of binding with maximum interacting surface area in the course of docking 
studies.
Conclusion: Our study suggests that based on different in silico parameters and molecular docking studies, naringenin can provide a new avenue for 
PD therapeutics.
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INTRODUCTION
Parkinson’s disease (PD) is the second most common 
neurodegenerative disorder characterized by dopamine depletion 
in the striatum. PD is characterized by bradykinesia, tremor, 
rigidity, and weakening of postural reflexes [1]. The dramatic loss of 
neuromelanin containing dopaminergic neurons is convoyed by the 
presence of Lewy bodies in the remaining neurons. The hallmark of 
PD includes fibrillar cytoplasmic inclusions comprising aggregated 
and abnormally accumulated proteins, the most prominent being 
α-synuclein, neurofilaments, ubiquitin, and ubiquitinated proteins 
[2]. In addition, at least 13 loci and nine genes have been proposed 
to be linked with PD, but only six genes are widely accepted to be 
associated with Mendelian forms of the disease [3]. Mutations in 
these genes potentially lead to autosomal dominant (α-synuclein 
and LRRK2) or autosomal recessive PD (Parkin, PINK1, DJ1, and 
ATP13A2). Recent epidemiological studies have shown that <10% 
of PD cases are of familial origin with the majority being sporadic 
[4]. The sporadic form of PD is caused by mutated DJ1 which shows 
reduced nuclear localization and translocation to mitochondria [5]. 
DJ-1 is ubiquitously expressed in a number of pathways associated 
with PD pathogenesis and has ubiquitin E3 ligase activity which also 
reduces α-synuclein aggregation [6]. Although mutations associated 
with DJ-1 lead to onset of familial PD, the exact mechanism behind 
the pathogenesis is still unknown [7]. Furthermore, various studies 
have advocated that several compounds of plant origin possess 
neuroprotective properties, however, their mode of action has not 
been clearly defined [8]. In this study, we have initially screened 
four biomolecules, namely, naringenin, quercetin, resveratrol, and 
sesamol based on Lipinski’s rule of five. These biomolecules are found 
in fruits and vegetables and have various beneficial effects such as 
antioxidative, activation of survival genes and signaling pathways, 
chelation of transition metal, regulating mitochondrial function, and 
modulating neuroinflammation. Further, these biomolecules interact 
with significant neuronal signaling cascades that lead to inhibition of 
apoptosis enhanced by the neurotoxic species and promote neuronal 
endurance and differentiation [9]. They selectively target a number 
of protein kinase and lipid kinase signaling cascades, importantly, 
the PI3K/Akt and MAP kinase pathways which modulate prosurvival 
transcription factors and gene expression [10]. Interestingly, naringenin 
treatment prominently suppressed oxidative stressors, improved 
levels of enzymatic antioxidants, and neurotransmitter significantly 
[11]. In this study, biomolecules which exhibit neuroprotective 
activities were subjected to docking simulations using AutoDock 
4.2.1. The preliminary investigation revealed naringenin as the best 
potential biomolecule among all given four biomolecules based on 
minimum inhibition constant, Ki, and highest negative free energy of 
binding with maximum interacting surface area with the active site of 
DJ-1 in a course of docking study. Based on in silico experimentation, 
naringenin is a seemingly new prospect for therapeutic intervention 
in PD. Therefore, a comprehensive understanding of the molecular 
mechanism associated with naringenin-mediated therapeutics could 
contribute toward clinical significance in PD biology.
METHODS
Retrieval of ubiquitin E3 ligase DJ-1 and their function recognition
The amino acid sequence of ubiquitin E3 ligase DJ-1 with accession 
numbers 4ZGG_A was retrieved from NCBI database and used for 
homology search using basic local alignment search tool (BLAST). 
Protein functional elucidation was done using Interproscan server 
(http://www.ebi.ac.uk/interpro/search/sequence-search/) [12].
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Phylogenetic relationship and physicochemical properties
For multiple sequence analysis, Muscle software (http://www.ebi.
ac.uk/Tools/msa/muscle/) was used and phylogenetic tree was 
constructed using muscle software based on neighbor joining plot 
without distance correction. ProtParam (http://web.expasy.org/
protparam/) was used to predict physicochemical properties [13]. The 
parameters computed by ProtParam included the molecular weight, 
theoretical PI, aliphatic index, and grand average of hydropathicity 
(GRAVY).
Homology modeling, visualization, and quality assessment of 
three-dimensional (3D) structure of ubiquitin E3 ligase DJ-1
Homology modeling was used to determine the 3D structure of 
DJ-1 isoforms. Templates with PDB ID 4ZGG were retrieved for DJ-1 
proteins from PDB. The protein structure prediction server Swiss-
model (http://swissmodel.expasy.org/) was used for homology 
model construction [14]. Once the 3D structure of proteins was 
generated, structural evaluation and stereochemical analysis 
were performed using RAMPAGE (http://www.mordred.bioc.cam.
ac.uk/~rapper/rampage.php). Errat server (http://nihserver.mbi.
ucla.edu/ERRATv2/) was used to find the accuracy of the structure 
and visualization of determined structures was performed using 
PyMOL viewer.
Ligand optimization
Reported ligand molecules (naringenin, quercetin, resveratrol, and 
sesamol) along with their physical and chemical properties were 
retrieved from PubChem compound database (http://www.pubchem.
ncbi.nlm.nih.gov/). SDF files of ligands were converted in PDB file 
with the help of Open Babel tool that could be used for docking study. 
Visualization of the molecular structure of compounds was done using 
PyMOL viewer.
Lipinski’s filter analysis of screened drugs
An online tool Lipinski’s filter (http://www.scfbio-iitd.res.in/software/
drugdesign/lipinski.jsp) was used to retrieve the information about 
druglikeness of drugs with the help of Lipinski’s rule of five. Lipinski’s 
rule (or Lipinski’s rule of five) helps to differentiate drug and non-drug-
like molecules [15]. It is used to identify the possibility of success or 
failure due to druglikeness for molecules fulfilling with two or more 
of the following rules: (a) Molecular mass should be <500 Da, (b) high 
lipophilicity (expressed as logP <5), (c) <5 hydrogen bond donors, 
(d) <10 hydrogen bond acceptors, and (e) molar refractivity should be 
between 40 and 130.
Active site prediction
CastP server (http://www.sts.bioe.uic.edu/castp/) was used to predict 
the active sites of protein [16]. CastP could also be used to measure 
area, circumference of mouth openings of each binding site insolvent, 
and molecular accessible surface. PDB file of protein was upload in the 
server and it showed the ligand binding sites present in protein and 
the site with maximum surface area and maximum surface volume 
was selected and all the amino acid residues involved in binding with 
ligands were retrieved.
Preparation of protein and ligand molecules
Preparation of protein involves the addition of polar hydrogen atoms, 
addition of charge, and removal of any miscellaneous structures from 
the protein molecule by Autodock 4.2.1, whereas ligand preparation 
involves the addition of charge.
Molecular docking analysis
Prepared and optimized structures of ligands and proteins were 
ultimately used for molecular docking using Autodock 4.2.1 for 
predicting the possible protein–ligand interactions and the results that 
include the understanding of the association that involves H-bonding 
and hydrophobic interactions were analyzed using LIGPLOT1.4.5, a 
program to generate schematic diagrams of protein–ligand interactions.
RESULTS
Retrieval of ubiquitin E3 ligase DJ-1 and their functional 
elucidation
Based on functional domain sequence of well-characterized 
gene/protein, homology search was performed using BLAST. We 
have successfully hunted 5 isoforms of protein DJ-1 (Table 1) on the 
basis of families and domains identified from Interproscan results. 
Interproscan study revealed that all homologues proteins for DJ-1, 
all homologous proteins were belonging to DJ-1 family (IPR006287), 
glutamine amidotransferase-like domain (IPR029062), and DJ-1/PfpI 
domain (IPR002818), respectively (Fig. 1).
Phylogenetic relationship and physicochemical properties
For multiple sequence analysis, Muscle software was used and found 
that amino acid residues were conserved in most of the isoforms of the 
ubiquitin E3 ligase DJ-1. Phylogenetic study of DJ-1 hunted proteins 
revealed that PD (autosomal recessive, early-onset) 7 and protein DJ-1 
were differing from others (Fig. 2a and b). However, another Chain 
A (crystal structure of aggregated form of DJ-1 Chain A) and Chain A 
(crystal structure of E18a human DJ-1) were in same cluster as share 
more homology while crystal structure of human DJ-1 was in another 
cluster. ProtParam showed that molecular weight of DJ-1 was 19848.7 
Da and an isoelectric point of DJ-1 was 6.37 which indicate that DJ-1 was 
negatively charged, respectively. Furthermore, GRAVY index of -0.47 for 
DJ-1 is indicative of hydrophilic (Table 2).
Homology modeling, 3D structure visualization, and quality 
assessment of retrieved proteins
Prediction of 3D structure of proteins provides us precise functional 
information of how proteins interact and localize in their stable 
conformation. Homology modeling is one of the most common 
Table 1: Hunted DJ-1-related proteins
S.No. Accession Protein Score Identity (%) E value
1 NP_009193.2 Protein DJ-1 368 98 5.00e-127
2 3BWE_A Chain A, crystal structure of aggregated form of DJ-1 365 100 6.00e-126
3 4OQ4_A Chain A, crystal structure of E18a human DJ-1 361 97 2.00e-124
4 1J42_A Chain A, crystal structure of human DJ-1 363 97 2.00e-125
5 ADQ32403.1 Parkinson disease (autosomal recessive, early-onset) 7 364 97 1.00e-125
Fig. 1: Interproscan result for DJ-1
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structure prediction tools in structural genomics and proteomics. 
The best matching template was selected for the target protein on 
the basis of sequence homology using PDB advance blast. Template 
is experimentally determined 3D structure of protein that shares 
sequence similarity with target sequence. Template showed sequence 
identity of 100% for DJ-1 isoforms. 3D structure of DJ-1 was generated 
using Swiss-model server. The Z-score is indicative of overall model 
quality and is used to check whether the input structure is within 
the range of scores typically found for native proteins of similar size. 
Z-score of the template and query model was obtained by Swiss-
model. Z-score for DJ-1 has been shown in (Table 3), suggesting a good 
structure.
3D structure of DJ-1 was generated. Even though there were no steric 
clashes in the structure generated, these were assessed for geometric 
and energy aspects (Fig. 3a). Ramachandran plot was used to check 
the reliability of predicted 3D structure of ubiquitin E3 ligase proteins 
DJ-1. RAMPAGE checks the stereochemical quality of a protein structure 
by analyzing residue-by-residue geometry and overall structure 
geometry. Ramachandran plots were obtained for DJ-1 for quality 
assessment (Fig. 3b). RAMPAGE displayed 99.5% of residues in the 
most favored regions, 0% residues in additionally allowed, and 0.5% 
disallowed regions of DJ-1 protein. Errat server was used to find the 
accuracy of the model. Result of Errat showed 98.844% of accurate 
structure for DJ-1 proteins.
Physicochemical properties and Lipinski’s filter analysis retrieved 
of ligands
Initial screening of the molecules was done on the basis of Lipinski’s 
rule of five (Fig. 4). Lipinski’s filter analysis revealed that all these 
molecules (naringenin, quercetin, resveratrol, and sesamol) could act 
as a drug as they meet the criteria of Lipinski’s rule of five. Further, the 
physicochemical properties of these selected biomolecules have been 
outlined in (Table 4).
Active site prediction and molecular docking analysis of DJ-1 with 
identified molecules
CastP server was used to predict the ligand binding site. This server 
calculates the possible active sites from the 3D atomic coordinates 
of the proteins. For DJ-1, residues involved in ligand binding site, 
site volume, and volume of protein for 33 active sites were predicted 
(Fig. 3c). Among the 33 binding sites obtained from CastP for DJ-1, 
site 33 was highly conserved within the active site of the protein. The 
predicted site 33 comprised 435.6 Å3 site volume out of the 1723.5 Å3 of 
protein volume. The residues in site 33 are shown in (Table 6).
Molecular docking pattern of DJ-1 with screened molecules (naringenin, 
quercetin, resveratrol, and sesamol) has been identified and depicted in 
(Fig. 5). On the basis of docking analysis, interacting compounds with 
minimum binding constant and highest negative free energy of binding 
are most effective. Docking calculation of DJ-1 has been presented in 
(Table 5).
Binding site residues of DJ-1 interacting with naringenin, quercetin, 
resveratrol, and sesamol were found to be the same as the residues 
involved in their respective catalytic sites. Interacting residues of 
DJ-1 with naringenin, quercetin, resveratrol, and sesamol along with 
Table 2: Physicochemical properties of DJ-1
Properties DJ-1
Molecular formula C874H1448N242O268S8




GRAVY: Grand average of hydropathicity
Table 3: Swiss-model server result showing template structure 
used in homology modeling, sequence identity, and quality 











DJ-1 2-185 4ZGG 100 −0.42
Fig. 3: Three-dimensional (3D) structure, Ramachandran plot, 
and active site of DJ-1 models. (a) Demonstrates 3D structure 
of DJ-1, (b) Ramachandran plot was obtained for quality 
assessment, and (c) Ligand binding site in DJ-1
c
ba
Fig. 4: Druglikeness prediction using Lipinski’s filter analysis
Fig. 2: (a) Multiple sequence alignment of all DJ-1 isoforms and 
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their identified catalytic sites have been shown in (Table 6) and 
their two-dimensional and 3D pattern of interaction is presented in 
(Fig. 6).
DISCUSSION
Despite the knowledge of various factors which contribute in the 
occurrence and progression of PD, the exact cause and cure remains 
elusive. Mutations in PD-associated genes potentially lead to autosomal 
dominant (α-synuclein and LRRK2), or autosomal recessive PD 
(Parkin, PINK1, DJ1, and ATP13A2), respectively [17]. Moreover, 
these genes display characteristic ubiquitin E3 ligase activity. DJ-1 is 
ubiquitously expressed in a number of pathways associated with PD 
pathogenesis and has ubiquitin E3 ligase activity which also reduces 
α-synuclein aggregation [18]. Thus, it seems imperative to design 
therapeutic strategies aimed at elevating the level of DJ-1 to improve 
neuronal survival in PD. Further, various studies have advocated that 
several compounds of plant origin possess neuroprotective properties, 
however, their mode of action have not been clearly defined [19]. 
Based on docking study analysis, the present study provides scientific 
evidence that given four biomolecules, namely, naringenin, quercetin, 
resveratrol, and sesamol are interacting at the reported binding 
site of DJ-1. Further, binding constant, Kb of naringenin, quercetin, 
resveratrol, and sesamol for DJ-1 was found to be 851.70 µM, 1.24 mM, 
4.25 mM, and 5.51 mM, respectively, suggesting that all the selected 
compounds might be effective as activators of E3 ligase activity of DJ-1. 
Furthermore, investigation of binding sites within DJ-1 gives a better 
idea for a valuable drug target site with highest binding and interaction 
affinity. Based on in vivo experimentation, the most effective compound 
in modulating E3 ligase activity of DJ-1 was found to be naringenin 
Fig. 5: Docking study of DJ-1 protein with selected compounds. 
(a) DJ-1 interaction with naringenin, (b) DJ-1 interaction with 




























Naringenin −4.19 851.70 µM −5.38 −5.25 −0.13 +9.69 +1.19
Quercetin −3.97 1.24 mM −5.76 −5.54 −0.22 +9.44 +1.79
Resveratrol −3.24 4.25 mM −5.03 −4.91 −0.12 +17.09 +1.79
Sesamol −3.08 5.51 mM −3.38 −3.12 −0.26 +0.32 +0.30
Table 4: Physicochemical properties of ligands
Characteristics Naringenin Quercetin Resveratrol Sesamol
Molecular 
weight (g/mol)
272.25278 302.2357 228.24328 138.12074
Molecular 
formula
C15H12O5 C15H10O7 C14H12O3 C7H6O3
Molecular 
structure
    







xLogP 2.4 1.5 3.1 1.2
Hydrogen bond 
donor
3 5 3 1
Hydrogen bond 
acceptor
5 7 3 3
Rotatable bond 
count




87 127 60.7 38.7
Heavy atom 
count
20 22 17 10




1 1 1 1
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Fig. 6: Binding site of DJ-1 with selected compounds along with 
its known stimulatory active site. (a) Three-dimensional (3D) 
presentation of DJ-1 and naringenin with their interacting 
residues, (b) 3D representation of DJ-1 and quercetin with 
their interacting residues, (c) 3D representation of DJ-1 and 
resveratrol with their interacting residues, (d) 3D representation 
of DJ-1 and sesamol with their interacting residues, (e) two-
dimensional (2D) representation of DJ-1 and naringenin with 
their interacting residues, (f) 2D representation of DJ-1 and 
resveratrol with their interacting residues, (g) 2D representation 
of DJ-1 and resveratrol with their interacting residues, and 






having minimum binding constant Kb and highest negative free energy 
of binding with maximum interacting surface area in a course of 
docking studies [20-25].
CONCLUSION
In this study, the sequence and structure analysis of ubiquitin E3 ligase 
protein DJ-1 were done by various computational tools and softwares. 
Molecular docking study advocated naringenin to be the most effective 
compound in elevating E3 ligase action of DJ-1 based on highest 
negative free energy of binding, minimum inhibition constant Ki, and 
maximum interacting surface area among the given four biomolecules. 
Such biomolecules can be effectively used to validate in vitro and in vivo 
prosurvival outcomes in PD models as well as in clinical scenario. 
Knowledge gained from this study can be used in broad screening of 
neuroprotective biomolecules and can be further implemented in 
designing effective therapeutics for PD.
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